Results 151 to 158 of about 955 (158)

Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy

Blood, 2013
David Belada, Tanin Intragumtornchai, Maria Gomes da Silva   +2 more
exaly  

PRIMA-1met radiosensitizes prostate cancer cells independent of their MTp53-status

Radiotherapy and Oncology, 2008
Stéphane Supiot, Klas G Wiman, Robert Bristow   +2 more
exaly  

Exploring Prima-1MET as a single agent or in combination with tamoxifen in breast cancer cells in vitro

European Journal of Pharmacology
Ali Haider Alhammer, Shahad Ali Mudhafar, Shaimaa Yousif Abdulfattah   +2 more
openaire   +1 more source

PRiMA

Neuron, 2002
Anselme L Perrier, Eric Krejci
exaly  

PRIMA‐1 induces p53‐mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation

Cancer Science, 2018
Haruna Furukawa, Tomoki Makino, Koji Tanaka   +2 more
exaly  

PRIMA-1MET/APR-246 targets mutant forms of p53 family members p63 and p73

Oncogene, 2010
exaly  

The PRIMA facility phase-referenced imaging and micro-arcsecond astrometry

New Astronomy Reviews, 2008
exaly  

First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial

Lancet, The
exaly